Yang Ping said, "We can't yet say it's cured, but recent follow-up examinations have already confirmed that within the observable range, tumor cells have been completely cleared."
"The progress of this project is astounding," Professor Su said happily, feeling more joy from his juniors' achievements than his own.
Yang Ping continued, "We plan to simultaneously start Phase I and II clinical trials, and conduct them in China, the USA, and Europe, obtaining global patient data all at once."
Professor Su is aware of the difficulty in applying for Phase I and II clinical trials in Europe and America for a drug or a new treatment method, but didn't expect Yang Ping's application to go so smoothly.
However, at the European Spine Academic Conference, Professor Su also experienced Yang Ping's influence, because he is Yang Ping's father-in-law, and received extremely honorable treatment there.
